United Therapeutics (UTHR) Misses Q4 EPS by 21c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $538.30 --0%
Revenue Growth %: +1.5%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +1.5%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.51, $0.21 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $427.62 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Amylyx ALS drug shows no serious adverse events in Phase 1 trial
- AMC Entertainment prices $200M stock offering to redeem senior notes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
